Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 3
1951 1
1952 5
1953 3
1955 1
1956 1
1959 1
1960 4
1961 5
1962 5
1963 5
1964 4
1965 7
1966 10
1967 11
1968 14
1969 20
1970 14
1971 8
1972 15
1973 2
1974 7
1975 13
1976 13
1977 5
1978 13
1979 19
1980 30
1981 17
1982 21
1983 18
1984 19
1985 12
1986 16
1987 9
1988 20
1989 22
1990 17
1991 23
1992 31
1993 23
1994 27
1995 17
1996 21
1997 6
1998 22
1999 23
2000 15
2001 22
2002 25
2003 29
2004 40
2005 28
2006 30
2007 34
2008 30
2009 33
2010 32
2011 43
2012 46
2013 91
2014 99
2015 110
2016 97
2017 104
2018 102
2019 122
2020 130
2021 160
2022 164
2023 159
2024 141
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,288 results

Results by year

Filters applied: . Clear all
Page 1
Role of Radiologists in Contract Research Organizations (CROs).
Mew A, Smith DA, Cole J, Sadow C, Tirumani SH, Ramaiya NH. Mew A, et al. Curr Probl Diagn Radiol. 2023 Mar-Apr;52(2):77-83. doi: 10.1067/j.cpradiol.2022.11.013. Epub 2022 Nov 17. Curr Probl Diagn Radiol. 2023. PMID: 36481295 Review.
However, the increasing scale of trials and the complexity of the regulatory approval process is often a barrier for those interested in conducting research. Contract research organizations (CROs) aim to address this problem by offering their infrastructure and expertise t …
However, the increasing scale of trials and the complexity of the regulatory approval process is often a barrier for those interested in con …
CROs and CNS research: challenges and trends.
Olugemo K. Olugemo K. Drug Discov Today. 2018 Jun;23(6):1167-1168. doi: 10.1016/j.drudis.2018.01.041. Epub 2018 Jan 31. Drug Discov Today. 2018. PMID: 29378251 No abstract available.
CroS(R391) , an ortholog of the lambda Cro repressor, plays a major role in suppressing polV(R391) -dependent mutagenesis.
McDonald JP, Quiros DR, Vaisman A, Mendez AR, Reyelt J, Schmidt M, Gonzalez M, Woodgate R. McDonald JP, et al. Mol Microbiol. 2021 Sep;116(3):877-889. doi: 10.1111/mmi.14777. Epub 2021 Jul 12. Mol Microbiol. 2021. PMID: 34184328 Free PMC article.
Levels of RumA are dependent upon an interplay between SetR(R391) and CroS(R391) , with the greatest reduction of RumA protein levels observed in the absence of SetR(R391) and the presence of CroS(R391) . ...Furthermore, deletion of croS(R391) on the native R …
Levels of RumA are dependent upon an interplay between SetR(R391) and CroS(R391) , with the greatest reduction of RumA protein levels …
Cochlear Implantation and Other Treatments in Single-Sided Deafness and Asymmetric Hearing Loss: Results of a National Multicenter Study Including a Randomized Controlled Trial.
Marx M, Mosnier I, Venail F, Mondain M, Uziel A, Bakhos D, Lescanne E, N'Guyen Y, Bernardeschi D, Sterkers O, Deguine O, Lepage B, Godey B, Schmerber S, Bonne NX, Vincent C, Fraysse B. Marx M, et al. Audiol Neurootol. 2021;26(6):414-424. doi: 10.1159/000514085. Epub 2021 Mar 31. Audiol Neurootol. 2021. PMID: 33789270 Free PMC article. Clinical Trial.
In total, 155 subjects with SSD or AHL, with or without associated tinnitus, were enrolled. After 2 consecutive trials with CROS hearing aids and BAHSs on headband, all subjects chose any of the 4 treatment options (abstention, CROS, BAHS, or cochlear implant [CI]). …
In total, 155 subjects with SSD or AHL, with or without associated tinnitus, were enrolled. After 2 consecutive trials with CROS hear …
The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies - The Cardiac Rehabilitation Outcome Study (CROS).
Rauch B, Davos CH, Doherty P, Saure D, Metzendorf MI, Salzwedel A, Völler H, Jensen K, Schmid JP; ‘Cardiac Rehabilitation Section’, European Association of Preventive Cardiology (EAPC), in cooperation with the Institute of Medical Biometry and Informatics (IMBI), Department of Medical Biometry, University of Heidelberg, and the Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Heinrich-Heine University, Düsseldorf, Germany. Rauch B, et al. Eur J Prev Cardiol. 2016 Dec;23(18):1914-1939. doi: 10.1177/2047487316671181. Epub 2016 Oct 25. Eur J Prev Cardiol. 2016. PMID: 27777324 Free PMC article. Review.
CCSs evaluating ACS patients showed a significantly reduced mortality for CR participants (pCCS: hazard ratio (HR) 0.37, 95% confidence interval (CI) 0.20-0.69; rCCS: HR 0.64, 95% CI 0.49-0.84; odds ratio 0.20, 95% CI 0.08-0.48), but the single RCT fulfilling Cardiac Rehabilitati …
CCSs evaluating ACS patients showed a significantly reduced mortality for CR participants (pCCS: hazard ratio (HR) 0.37, 95% confidence inte …
Pirates of Clinical Trials.
Pergolizzi J Jr, Pergolizzi C, LeQuang JAK. Pergolizzi J Jr, et al. Cureus. 2023 Oct 27;15(10):e47819. doi: 10.7759/cureus.47819. eCollection 2023 Oct. Cureus. 2023. PMID: 38022306 Free PMC article.
CROs establish agreements with sponsors, including how much a site will be paid per study subject. ...The result is a competitive market place that favors big sponsors and puts smaller CROs and start-ups at a disadvantage....
CROs establish agreements with sponsors, including how much a site will be paid per study subject. ...The result is a competitive mar …
[An astonishing diagnosis!].
Morini A, Burys A, Cazals-Hatem D, Sauvanet A, Fléjou JF, Cros J. Morini A, et al. Ann Pathol. 2023 Sep;43(5):421-424. doi: 10.1016/j.annpat.2023.01.002. Epub 2023 Jan 24. Ann Pathol. 2023. PMID: 36702725 French. No abstract available.
A comparison between wireless CROS/BiCROS and soft-band BAHA for patients with unilateral hearing loss.
Choi JE, Ma SM, Park H, Cho YS, Hong SH, Moon IJ. Choi JE, et al. PLoS One. 2019 Feb 21;14(2):e0212503. doi: 10.1371/journal.pone.0212503. eCollection 2019. PLoS One. 2019. PMID: 30789931 Free PMC article.
Pseudobinaural benefits (e.g., squelch, summation, and head shadow effect) were obtained in both the CROS/BiCROS and soft-band BAHA conditions and compared to the unaided condition. Sound localization ability was not improved in either the CROS/BiCROS condition or s …
Pseudobinaural benefits (e.g., squelch, summation, and head shadow effect) were obtained in both the CROS/BiCROS and soft-band BAHA c …
2,288 results